Ping An Biomedical Co., Ltd. (PASW) - Total Assets
Based on the latest financial reports, Ping An Biomedical Co., Ltd. (PASW) holds total assets worth $68.41 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See PASW total equity for net asset value and shareholders' equity analysis.
Ping An Biomedical Co., Ltd. - Total Assets Trend (2021–2025)
This chart illustrates how Ping An Biomedical Co., Ltd.'s total assets have evolved over time, based on quarterly financial data.
Ping An Biomedical Co., Ltd. - Asset Composition Analysis
Current Asset Composition (September 2025)
Ping An Biomedical Co., Ltd.'s total assets of $68.41 Million consist of 93.1% current assets and 6.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.7% |
| Accounts Receivable | $16.93 Million | 24.8% |
| Inventory | $441.90K | 0.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Ping An Biomedical Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Ping An Biomedical Co., Ltd. market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ping An Biomedical Co., Ltd.'s current assets represent 93.1% of total assets in 2025, a decrease from 95.5% in 2021.
- Cash Position: Cash and equivalents constituted 1.7% of total assets in 2025, up from 0.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 24.8% of total assets.
Ping An Biomedical Co., Ltd. Competitors by Total Assets
Key competitors of Ping An Biomedical Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HMT(Xiamen)New Technical
SHG:603306
|
China | CN¥5.86 Billion |
|
Bros Eastern Co Ltd
SHG:601339
|
China | CN¥13.55 Billion |
|
Vardhman Textiles Limited
NSE:VTL
|
India | Rs131.53 Billion |
|
Huafu Top Dyed Melange Yarn Co Ltd
SHE:002042
|
China | CN¥16.51 Billion |
|
Hunan Huasheng Co Ltd
SHG:600156
|
China | CN¥834.37 Million |
|
Huafang Co Ltd
SHG:600448
|
China | CN¥3.70 Billion |
|
Indo Kordsa Tbk
JK:BRAM
|
Indonesia | Rp268.28 Million |
|
Daehan Synthet
KO:003830
|
Korea | ₩812.49 Billion |
Ping An Biomedical Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.76 | 0.84 | 0.90 |
| Quick Ratio | 2.74 | 0.84 | 0.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $40.62 Million | $-10.27 Million | $-8.65 Million |
Ping An Biomedical Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Ping An Biomedical Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.52 |
| Latest Market Cap to Assets Ratio | 0.27 |
| Asset Growth Rate (YoY) | 20.3% |
| Total Assets | $68.41 Million |
| Market Capitalization | $18.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ping An Biomedical Co., Ltd.'s assets below their book value (0.27x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ping An Biomedical Co., Ltd.'s assets grew by 20.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ping An Biomedical Co., Ltd. (2021–2025)
The table below shows the annual total assets of Ping An Biomedical Co., Ltd. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $68.41 Million | +20.34% |
| 2024-09-30 | $56.85 Million | -28.80% |
| 2023-09-30 | $79.84 Million | -2.57% |
| 2022-09-30 | $81.95 Million | +11.18% |
| 2021-09-30 | $73.71 Million | -- |
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finish… Read more